Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients

Includes abstract.

Saved in:
Bibliographic Details
Main Author: Swart, Marelize
Other Authors: Dandara, Collet
Format: Thesis
Language:English
Published: Department of Medicine 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614026538680320
access_status_str Open Access
author Swart, Marelize
author2 Dandara, Collet
author_browse Dandara, Collet
Swart, Marelize
author_facet Dandara, Collet
Swart, Marelize
author_sort Swart, Marelize
collection Thesis
description Includes abstract.
format Thesis
id oai:open.uct.ac.za:11427/11835
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:45:30.069Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2015
publishDateRange 2015
publishDateSort 2015
publisher Department of Medicine
publisherStr Department of Medicine
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/11835 Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients Swart, Marelize Dandara, Collet Medicine Includes abstract. Includes bibliographical references (leaves 82-96). Efavirenz (EFV) is used in first-line antiretroviral (ARV) therapy of HIV-infected patients, and is principally metabolised by CYP1A2, CYP2A6, CYP2B6, CYP3A4/5 and the drug transporter ABCB1. Genetic variability in the above genes may contribute to differences in EFV plasma concentrations which affect the levels of viral suppression as well as development of side effects in patients. The aim of this project was to evaluate the effects of the different genetic polymorphisms on EFV plasma concentration levels in HIV/AIDS patients receiving first-line antiretroviral treatment (ART) containing EFV. 2015-01-09T08:56:56Z 2015-01-09T08:56:56Z 2011 Master Thesis Masters MSc http://hdl.handle.net/11427/11835 eng application/pdf Department of Medicine Faculty of Health Sciences University of Cape Town
spellingShingle Medicine
Swart, Marelize
Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
thesis_degree_str Master's
title Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
title_full Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
title_fullStr Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
title_full_unstemmed Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
title_short Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
title_sort pharmacogenetics of efavirenz response in bantu speaking south african hiv aids patients
topic Medicine
url http://hdl.handle.net/11427/11835
work_keys_str_mv AT swartmarelize pharmacogeneticsofefavirenzresponseinbantuspeakingsouthafricanhivaidspatients